Latest Publications Events Webinars Recognition Resources

Firm News

Oblon Ranked in Chambers USA 2021

Firm News

World IP Day 2021

Firm News

LES 2021 Updates

PTAB Update: APJs "Unreviewable Authority" Reigned In By Supreme Court, But the IPR Process Survives

Application of AI in Legal Services

The Pros and Cons of Asserting U.S. Patents against Foreign Companies

Joint International Symposia on US/EU Patent Practice 2021

Recent Trends in Post Grant PracticeREWATCH NOW

Doctrine of Equivalents, Where Are We Now?REWATCH NOW

Asserting U.S. Patents Against Foreign Companies: Considerations For Litigating U.S. Patents Against Entities Without a Significant U.S. PresenceREWATCH NOW

Oblon Named a "Best Law Firm 2020"

Nine Oblon Attorneys Recognized as Best Lawyers 2020

Nine Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.

Oblon Ranked Again in IAM Patent 1000

Oblon's Patent Prosecution practice and partners from the firm's Chemical, Electrical & Mechanical and Litigation practices have received top national rankings in the 2019 edition of IAM Patent 1000: The World's Leading Patent Professionals.

Find a Person

Type a name

Type a keyword

Select a position

Select a service

7490
7491
7492
7493
7494
7496
7495
7497

Select an Technology

924
794
797
925
795
799
796
798

Select an office

619
618

Select a language

Select a school

Showing 3 of 10

People Services Newsroom Publications Events Others

Publications

June 21, 2021 – ArticlePTAB Update: APJs "Unreviewable Authority" Reigned In By Supreme Court, But the IPR Process Survives

June 11, 2021 – ArticleApplication of AI in Legal Services

June 2, 2021 – ArticleThe Pros and Cons of Asserting U.S. Patents against Foreign CompaniesIP Litigator

June 2, 2021 – ArticleFourth Circuit Holds that Equitable Defense of Laches, Not Most Analogous Statute of Limitations, Applies to Section 43(a) Claims

May 28, 2021 – ArticleProtecting the Data that Fuels AI

May 20, 2021 – ArticleNew Legislation Supports Biosimilar Drugs, Clarifies Qualifications for Obtaining FDA Exclusivity

May 10, 2021 – ArticleReliance on a Single Non-Enabling Reference to Establish Obviousness

May 4, 2021 – ArticleNCE Status Now Limited Active Moieties

April 30, 2021 – ArticleDisclosing AI Inventions - Part II: Describing and Enabling AI Inventions

April 26, 2021 – ArticlePTAB Restates That Not All Combinations of Molecular Modifications are Obvious

April 22, 2021 – ArticleIn re Rudy and the PTO 101 Guidance

April 21, 2021 – ArticleNHK-Fintiv Rule - APA Violation?

April 16, 2021 – ArticleDrafting Claims for Supervised Machine-Learning Systems

April 15, 2021 – ArticleIndefiniteness: Bad Translation/Lack of Definition Redux

April 12, 2021 – ArticleFrance is a WIPO Digital Access (DAS) Participating Office

April 9, 2021 – ArticleDisclosing AI Inventions - Part I: Identifying the Unique Disclosure Issues

April 7, 2021 – ArticlePharma Companies Must Factor Tough Standing Requirements into IPR StrategiesIAM Media

April 6, 2021 – ArticleNHK-Fintiv Rule Challenges Look Futile at Federal Circuit

April 6, 2021 – ArticleClaims Directed to Computerized Statistical Methods for Determining Haplotype Phase Are Patent Ineligible

March 17, 2021 – ArticleInvention and Conception: The AI Conundrum

March 10, 2021 – ArticleFederal Circuit Finds That IPR Estoppel—Including Underlying Real-Party-In-Interest Findings—May Be Reviewable Even After Thryv v. Click-to-Call

March 8, 2021 – ArticleInvalidation of Chemical Compound Claims

March 5, 2021 – ArticleTracking AI Prosecution Trends at the U.S. Patent Office

March 3, 2021 – ArticleShould You Patent Your Own Company's Software?

March 1, 2021 – ArticleGlaxoSmithKline v. Teva – Not A Skinny Label?

February 25, 2021 – ArticleAI Patent Trends in the U.S. Patent Office: Is the U.S. Losing Its Lead?

February 12, 2021 – ArticleSupreme Court Declines to Hear Idenix Case: Dispute Surrounding the Enablement Standard for Biotechnology Patents Continues

February 10, 2021 – ArticleAI Initiatives at the JPO

February 10, 2021 – ArticleThe "Skinny Label" - The Federal Circuit Has Second Thoughts

February 4, 2021 – ArticleTwo-Step Eligibility for Genomic Analysis Systems

February 1, 2021 – ArticleUSPTO: Proposed Changes to Terminal Disclaimer Practice in Joint Research Agreement Situations

January 29, 2021 – ArticleAI Initiatives at the EPO

January 29, 2021 – ArticlePTAB Trends and Predictions: Looking Back at 2020 and Forward to 2021

January 15, 2021 – ArticlePatent Issues for Factory Automation Inventions in AI

January 8, 2021 – ArticleThe Purple Book Continuity Act

January 4, 2021 – ArticleSmall Entity Government Use License Exception: Amendment of the Rules of Practice in Patent Cases

December 21, 2020 – ArticleShould Companies Suspend Patent Rights on COVID-19 Vaccines?

December 7, 2020 – ArticleGSK v Teva – The Federal Circuit's First Look at Skinny Labels and 35 U.S.C. 271(b)

December 4, 2020 – ArticleWhat is "About" All About?

November 24, 2020 – ArticleThe Presumption Against Extraterritoriality's Slow Decline in Patent LawAIPLA Quarterly Journal

November 12, 2020 – ArticleUsing AI to Track AI Patents at the USPTO

November 11, 2020 – ArticleUSPTO Releases Public Comments on AI

November 10, 2020 – ArticleSupreme Court Hears Oral Arguments on Affordable Care Act: Will Biosimilars Survive?

October 28, 2020 – ArticleCreation vs. Conception: Can an AI Machine be an Inventor?

October 27, 2020 – ArticleWhere Have All the Bio/Pharma IPRs Gone?

October 23, 2020 – ArticleUC Takes Next Step With Filament Light Bulb Case: Manufacturers and ITCTechnology Transfer Tactics

October 16, 2020 – ArticleMust a "Human Antibody" Be Entirely Human? Or May It Also Be "Partially Human?"

October 15, 2020 – ArticleRoku Beats $41M Infringement Claim In Texas TrialLaw360

October 13, 2020 – ArticleInadequate Translation of a Non-English Application Leads to US Patent Invalidation

October 13, 2020 – ArticleSafe Harbor (35 U.S.C. 271(e)(1)) and Medical Devices

Page 1 of 15
Next